AIDS HEALTHCARE FOUNDATION:
CUTTING EDGE MEDICINE AND ADVOCACY REGARDLESS OF ABILITY TO PAY
Advocacy at AHF has been pushing the boundaries in the name of basic human rights for over thirty years. It’s as fundamental to our organization as the care we give our patients. Over the years, we’ve grown from a small group of passionate activists into a major powerhouse for political, economic, and social change across the country.
Our campaigns work together to advocate for fundamental human rights that set the tone for health and wellness in the United States and beyond. We fight for lower drug prices, affordable housing, equal access to health care, and so much more. Our campaigns are varied, but they all have one thing in common; fighting for what's right.
Protect Grassroots Advocacy Today!
Grassroots advocacy is under attack!
Corporate landlord groups trying to raise rents during the COVID 19 pandemic are now attacking the loudest voice for low-income renter ballot initiatives in California - AIDS Healthcare Foundation.
AB 1938, a bill sponsored by the California Apartment Association, California Chamber of Commerce, and California Association of Realtors, is snaking its way through the state legislature.
While AB 1938 directly targets AIDS Healthcare Foundation, this bill will have dangerous ramifications for all advocacy efforts in the state of California.
Please join us in urging the members of the CA State Assembly Committee on Appropriations to vote NO on this deeply-flawed bill.
Housing is a Human Right
Unaffordable, unstable housing leads to negative health outcomes for all who experience it, especially those living with HIV and AIDS. The nationwide housing affordability crisis needs urgent action.
Medicare 4 All!
Access to health care is a human right. AHF endorses the Medicare-For-All Congressional proposal that would make tax-funded health care available to all Americans.
The 340B Drug Pricing Program helps provide better health outcomes for millions of Americans. The program is under attack from greedy pharmaceutical companies, but we’re not backing down without a fight.